185 related articles for article (PubMed ID: 22225916)
1. A photochemical approach for controlled drug release in targeted drug delivery.
Choi SK; Verma M; Silpe J; Moody RE; Tang K; Hanson JJ; Baker JR
Bioorg Med Chem; 2012 Feb; 20(3):1281-90. PubMed ID: 22225916
[TBL] [Abstract][Full Text] [Related]
2. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
Patri AK; Kukowska-Latallo JF; Baker JR
Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates.
Wu G; Barth RF; Yang W; Kawabata S; Zhang L; Green-Church K
Mol Cancer Ther; 2006 Jan; 5(1):52-9. PubMed ID: 16432162
[TBL] [Abstract][Full Text] [Related]
4. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
[TBL] [Abstract][Full Text] [Related]
5. Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach.
Zhang Y; Thomas TP; Desai A; Zong H; Leroueil PR; Majoros IJ; Baker JR
Bioconjug Chem; 2010 Mar; 21(3):489-95. PubMed ID: 20128612
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs.
Kojima C; Kono K; Maruyama K; Takagishi T
Bioconjug Chem; 2000; 11(6):910-7. PubMed ID: 11087341
[TBL] [Abstract][Full Text] [Related]
7. Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate.
Choi SK; Thomas TP; Li MH; Desai A; Kotlyar A; Baker JR
Photochem Photobiol Sci; 2012 Apr; 11(4):653-60. PubMed ID: 22234658
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of biodendrimeric β-cyclodextrin via click reaction with potency of anticancer drug delivery agent.
Toomari Y; Namazi H; Entezami AA
Int J Biol Macromol; 2015 Aug; 79():883-93. PubMed ID: 26056989
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of folic acid functionalized bioactive glass for targeted delivery and sustained release of methotrexate.
Chen J; Chen X; Yang Z; Tan X; Wang J; Chen Y
J Biomed Mater Res A; 2019 Feb; 107(2):319-329. PubMed ID: 30450695
[TBL] [Abstract][Full Text] [Related]
10. Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate.
Leng ZH; Zhuang QF; Li YC; He Z; Chen Z; Huang SP; Jia HY; Zhou JW; Liu Y; Du LB
Carbohydr Polym; 2013 Oct; 98(1):1173-8. PubMed ID: 23987460
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of the dendritic type β-cyclodextrin on primary face via click reaction applicable as drug nanocarrier.
Toomari Y; Namazi H; Akbar EA
Carbohydr Polym; 2015 Nov; 132():205-13. PubMed ID: 26256342
[TBL] [Abstract][Full Text] [Related]
12. Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.
Thomas TP; Joice M; Sumit M; Silpe JE; Kotlyar A; Bharathi S; Kukowska-Latallo J; Baker JR; Choi SK
Curr Pharm Des; 2013; 19(37):6594-605. PubMed ID: 23621534
[TBL] [Abstract][Full Text] [Related]
13. Tumour regression and improved gastrointestinal tolerability from controlled release of SN-38 from novel polyoxazoline-modified dendrimers.
England RM; Hare JI; Barnes J; Wilson J; Smith A; Strittmatter N; Kemmitt PD; Waring MJ; Barry ST; Alexander C; Ashford MB
J Control Release; 2017 Feb; 247():73-85. PubMed ID: 28043863
[TBL] [Abstract][Full Text] [Related]
14. Surface-engineered dendrimers for dual drug delivery: a receptor up-regulation and enhanced cancer targeting strategy.
Tekade RK; Dutta T; Tyagi A; Bharti AC; Das BC; Jain NK
J Drug Target; 2008 Dec; 16(10):758-72. PubMed ID: 18985508
[TBL] [Abstract][Full Text] [Related]
15. PEG-PEI-modified gated N-doped mesoporous carbon nanospheres for pH/NIR light-triggered drug release and cancer phototherapy.
Panda S; Bhol CS; Bhutia SK; Mohapatra S
J Mater Chem B; 2021 May; 9(17):3666-3676. PubMed ID: 33949617
[TBL] [Abstract][Full Text] [Related]
16. Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics.
Tekade RK; Dutta T; Gajbhiye V; Jain NK
J Microencapsul; 2009 Jun; 26(4):287-96. PubMed ID: 18791906
[TBL] [Abstract][Full Text] [Related]
17. Neem gum based pH responsive hydrogel matrix: A new pharmaceutical excipient for the sustained release of anticancer drug.
Mankotia P; Choudhary S; Sharma K; Kumar V; Kaur Bhatia J; Parmar A; Sharma S; Sharma V
Int J Biol Macromol; 2020 Jan; 142():742-755. PubMed ID: 31739022
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyl-modified magnetite nanoparticles as novel carrier for delivery of methotrexate.
Farjadian F; Ghasemi S; Mohammadi-Samani S
Int J Pharm; 2016 May; 504(1-2):110-6. PubMed ID: 26994523
[TBL] [Abstract][Full Text] [Related]
19. Transferrin Conjugated pH- and Redox-Responsive Poly(Amidoamine) Dendrimer Conjugate as an Efficient Drug Delivery Carrier for Cancer Therapy.
Hu Q; Wang Y; Xu L; Chen D; Cheng L
Int J Nanomedicine; 2020; 15():2751-2764. PubMed ID: 32368053
[TBL] [Abstract][Full Text] [Related]
20. Controlled release of methotrexate from functionalized silica-gelatin aerogel microparticles applied against tumor cell growth.
Nagy G; Király G; Veres P; Lázár I; Fábián I; Bánfalvi G; Juhász I; Kalmár J
Int J Pharm; 2019 Mar; 558():396-403. PubMed ID: 30664996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
